- New York hospital taps cardiology leader for president
- Washington hospital names new CEO
- How ambulatory care shifts are reshaping health system leadership structures
- Arkansas system inks 2nd hospital acquisition in 5 weeks
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The recent evolution of anesthesia strategy
- The future of medical-dental integration is here
- Trinity Health to open $226M replacement hospital April 19
- Sharp HealthCare taps Apple Vision Pro for surgical innovation
- The law that could help fix anesthesia reimbursement issues — and why it’s being ignored
- UW Health inks deal to become Packers’ official healthcare partner
- California hospital CEO steps down
- How CHS, HCA, Tenet, and UHS’ CEO-to-worker pay ratios ranked in 2025
- Texas dentist has license suspended
- RFK Jr. says he’ll reform preventive task force: 4 hearing takeaways
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- Stereotaxis to acquire cardiovascular robotics company for $45M
- Meritus Health adds Dr. Christine Lewis
- What’s the deal with insurer mental health parity violations?
- NYU Langone Health opens 12K-square-foot ambulatory location
- 10 anesthesia leadership appointments from Q1
- What could improve physician market competition
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- How ESOPs can help retiring physicians cash out
- Specialty1 Partners’ growth in 2026: 5 updates
- UnityPoint Health to transition dental services to FQHC
- The ownership opportunity ASCs are leaving behind
- New York hospital taps ambulatory operations leader
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- 4 DSOs adding new technology
- Aspen Dental opens Michigan office
- Studies reaffirm fluoride safety, benefits: 10 things to know
- New Oklahoma law closes dental insurer price fixing loophole
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- Kentucky approves changes to Dental Practice Act
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- ‘Mini specialists’: 5 models reshaping behavioral health in primary care
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- Progyny unveils new fertility benefit option for small, mid-size employers
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Chicago hospital expands outpatient, walk-in mental health services
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Bill would force payers to apply DTC drug purchases to patient deductibles
- 43 states have mental health insurance disparities: 4 trends
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- The new playbook for clinician well-being
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- Anthem, Mount Sinai reach contract agreement, restore in-network coverage
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Stanford Health Care, Alameda Health System partner to support St. Rose Hospital
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Statement Regarding Staff No-Action Letter to Bank of England
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
Brownstein Hyatt Farber Schreck (Wikipedia)
Their summary of the proposed federal budget is the best I found on a quick internet search. Please feel free to add others, especially more recent information.
I'll follow with an article on the importance of health policy in this election.
Biden Reveals Health Care Priorities in FY 2025 Budget
BROWNSTEIN CLIENT ALERT, MARCH 11, 2024
<clip>
A more detailed breakdown of the Department of Health and Human Services’ (HHS) budget request can be found here. The FY 2025 budget contains numerous health initiatives and priorities including:
- Reduces Drug and Other Health Care Costs for All Americans.
- Expands the IRA’s inflation rebates and $2,000 out-of-pocket prescription drug cost cap beyond Medicare and into the commercial market.
- Extends the $35 cost-sharing cap for a month’s supply of covered insulin products to the commercial market.
- Limits Medicare Part D cost-sharing for high-value generic drugs to no more than $2 for Medicare beneficiaries.
- Increases the pace of drug price negotiations by bringing more drugs into negotiation sooner after they launch.
- Authorizes HHS to negotiate supplemental drug rebates on behalf of interested states to pool purchasing power.
- Makes permanent the expanded Affordable Care Act (ACA) premium tax credits that were extended in the IRA.
- Provides Medicaid-like coverage to individuals in states that have not adopted Medicaid expansion, paired with financial incentives to ensure states maintain their existing expansions.
- Allows banning “facility fees” for telehealth and certain outpatient services in commercial insurance.
- Funds the continued implementation of the No Surprises Act.
- Honors America’s Commitment to Seniors and Americans in Need.
- Extends solvency of the Medicare Hospital Insurance (HI) trust fund indefinitely by ensuring high-income individuals pay their fair share.
- Proposes limiting the portion of Medicaid and CHIP managed care dollars spent on administration and incentivizing more investment in health care services by establishing a medical loss ratio.
- $150 billion over 10 years to improve and expand Medicaid home and community-based services (HCBS).
- Shifts funding for nursing home surveys from discretionary to mandatory beginning in 2026 and increases funding to cover 100% of statutorily mandated surveys.
- Proposes requiring greater transparency of nursing facility ownership and increasing the inspection of facilities with serious safety deficiencies.
- Invests in the Health and Well-Being of Families and the Next Generation.
- $390 million, a 36% increase above the 2023 enacted level, for the Title X Family Planning program to increase the number of patients served to 3.6 million.
- Transforms Behavioral Health Care.
- $1 billion to advance health information technology adoption and engagement in interoperability for certain behavioral health providers.
- Increases funding for the Children’s Mental Health Initiative by $50 million.
- Expands access to behavioral health services through investments in Certified Community Behavioral Health Clinics and Community Mental Health Centers.
- Doubles funding for the Mental Health Crisis Partnership Program.
- Invests in strengthening the behavioral health workforce, including integration into primary care settings.
- Proposes to extend incentive payment programs for Medicare providers in areas with clinician shortages to a broader set of clinicians, including behavioral health clinicians.
- Expands coverage of mental health benefits and strengthens the network of behavioral health providers in commercial insurance.
- Increases funding for the State Opioid Response grant program.
- Invests in a new technical assistance center to strengthen health providers’ understanding and treatment of substance use and women’s mental health.
- Invests in Medical Innovation, Scientific Breakthroughs and the Treatments of Tomorrow.
- $2 billion increase across the National Cancer Institute, Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and cancer projects at the Advanced Research Projects Agency for Health (ARPA-H).
- Additional mandatory funds for the Indian Health Service (IHS) beginning in 2026.
- Proposes creating a nationwide network of centers of excellence and innovation in women’s health.
- Doubles existing funding for the Office of Research on Women’s Health at the National Institutes of Health (NIH).
- Advances Health Equity.
- $376 million, an increase of $82 million above the 2023 enacted level, to support the ongoing implementation of the White House Blueprint for Addressing the Maternal Health Crisis.
- Expands Medicaid maternal health support services during the pregnancy and postpartum period by incentivizing states to reimburse a broad range of providers, including doulas, community health workers, peer support initiatives and nurse home visiting programs.
- $8 billion in discretionary resources in 2025, a 12% increase over the 2021 enacted level, for clinical services, preventative health, facilities construction, contract support costs and tribal leases at IHS.
- Proposes all IHS resources as mandatory beginning in 2026.
- Reauthorizes and increases funding for the Special Diabetes Program for Indians.
- Invests in direct primary care and mental health care services, expanded infrastructure and assistance for rural hospitals to remain open and provide high-quality services.
- Protects and Strengthens Public Health and Health Infrastructure.
- $2.5 billion in discretionary and mandatory funds over 10 years at CDC to support an evidence-based community violence initiative to address the causes of violence in communities and help reduce health inequities that characterize violence.
- $60 million for gun violence research across CDC and NIH.
- $9.8 billion in discretionary and mandatory funding for the Prevention and Public Health Fund, an increase of $499 million over the 2023 enacted level.
- $20 billion in mandatory funding for HHS public health agencies in support of the administration’s biodefense priorities as outlined in the 2022 National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security.
- $75 million in the Administration for Strategic Preparedness and Response (ASPR) to manufacture more essential medicines, medical countermeasures and critical inputs in the United States.
- $12 million to strengthen FDA’s capacity to identify and address potential disruptions and shortage threats.
- Expands end-to-end supply chain visibility to priority FDA-designated essential medicines and devices to prepare for and mitigate potential shortages.
- Creates a new office to coordinate agency-wide activities on supply chain resilience and shortage mitigation efforts for drugs, biologics, medical devices and critical foods.
- Proposes a national program to significantly expand screening, testing, treatment, prevention and monitoring of hepatitis C infections in the United States.
- Proposes a new mandatory program to guarantee PrEP at no cost for all uninsured and underinsured individuals.
- Proposes a new Vaccines for Adults program to provide uninsured adults with access to routine and outbreak vaccines at no cost.
- Invests in protecting the health care system from cyber threats and includes funding for ASPR to coordinate cybersecurity efforts.
- $800 million to help high-need, low-resourced hospitals cover the upfront costs associated with implementing essential cybersecurity practices.
- $500 million for an incentive program to encourage all hospitals to invest in advanced cybersecurity practices.
- $141 million to continue strengthening HHS’s ability to protect and defend HHS systems and information, including $11 million to expand and enhance HHS’ capacity to protect the privacy and security of health information.
- Invests in HHS’ role in promoting the use of artificial intelligence (AI) in health care and public health while protecting against its risks.
As mentioned above, the president’s budget request starts the congressional budget and appropriations process. The budget presented by the Biden administration provides an aspirational roadmap to what the president would like to be implemented and how much Congress integrates these ideas into their own remains to be seen.
Followers of the MHF Forum and Michigan health policy will recognize many of these funds already leveraging policy in our state.
Joe Grogan has penned an avowedly partisan recapitulation of the ways Medicare funding has been looted to finance non medical programs in recent years:
The Honest Truth About Health Policy
As a frail President Biden walks onto the debate stage this week with the considerable challenge of defending a disastrous record on foreign policy, inflation, and border policies, he is certain to try to use healthcare as an area to score points against President Trump. The campaign is already airing ads on the subject. The media largely ignored or misrepresented Trump’s record on healthcare but there is one area that probably can’t be ignored any longer: Biden’s Medicare policies are hitting seniors hard.As he works to boost support from seniors, Biden has attempted to paint Trump as a threat to Medicare, but the truth is that Biden and the Democrats raided Medicare for green energy subsidies and America’s seniors are paying the price. In 2022, Democrats rammed through the Inflation Reduction Act (IRA) with major changes to Medicare’s prescription drug reimbursement—previously an area of bipartisanship—without a single Republican vote.
President Trump by contrast quietly pursued bipartisan changes, engaging with Senators Grassley and Wyden, Majority Leader McConnell and Speaker Pelosi for negotiations on a bipartisan drug pricing bill to help seniors manage drug costs and preserve the program, but that construct was tossed aside when Democrats took both legislative chambers and the White House and had the chance to implement drug price controls.
Much has been written about how Biden’s drug price setting scheme has led numerous developers to cancel research programs, and more cancellations are around the corner. But what has not gotten enough attention is that in a real feat of policy incompetence, cost savings for seniors are still years away, but seniors are already paying more for drug coverage. Plans requested an average premium increase of 21.5% for 2024 and requests will likely be elevated for 2025 as well. While Democrats included a cap on one factor used to determine beneficiary premiums, the cap does not extend to the premium as a whole. This, coupled with poorly designed changes to Medicare Part D’s structure triggered astronomical premium increases.
Part D instability will grow in 2025 and 2026 as the program’s price fixing provisions kick in and the rebates that keep premiums down disappear. Premiums will need to go up or benefit generosity will need to go down. Some plans may simply stop offering coverage in certain areas next year.
Why would Democrats destabilize the program and impose higher costs on seniors? A generous explanation might be that they didn’t think that this many drug development programs would get cancelled and they didn’t understand that the changes they were making to Part D’s structure would be catastrophic. But a more ideological explanation, and I think a more accurate one, is that Democrats just got greedy, which is ironic since this is their standard attack line against drug companies.
When President Trump proposed restructuring Part D to help seniors, all of the savings in drugs costs accrued to seniors and stayed in the Medicare program. But Democrats needed to loot Part D to pay for the green energy subsidies of the IRA.
Put another way, Biden cut benefits from people with a median income of $36,000 per year to subsidize cars purchased by individuals who earn five times as much. This $240 billion raid on Medicare would be shocking if they hadn’t done it before; Democrats cut $450 billion to $716 billion from Medicare to fund the Affordable Care Act.
When Republicans had both legislative houses and the White House under President Trump, we cut taxes. When Democrats had both houses under Obama and Biden, they raided Medicare to create new programs.
So, when Biden says Medicare won’t be cut on his watch, people should know he already did. Under Donald Trump; benefits were made more generous, particularly for Medicare Advantage enrollees, who Trump allowed to better manage their chronic conditions with enhanced benefits, such as home modifications to address disability. Ironically, the Biden Administration has spent the last three years squeezing Medicare Advantage and costing seniors more money. All the while, they have demonized for-profit companies in health care as they waged war against them.
For the first time in history Thursday night’s debate will feature two candidates who have both held the office defending their records, attacking the other’s. Biden’s team is hoping healthcare might provide a rare window to go on offense, but their actions while in office betray them. And by any objective measure, Trump’s record protecting Medicare is far better than the Biden record of looting it.
During the ACA/Obamacare debates, "Healthcare is 1/6 of the economy" became common knowledge.
Yes. They are connected.
In this timely debate prep, NBC refreshes our frame of reference.
Health care just as important as economy. What experts want Biden and Trump to address.
About half of U.S. adults say it is difficult to pay for their medical care. June 26, 2024, 11:03 AM EDTWhen President Joe Biden and former President Donald Trump face off Thursday during the first general election debate, health policy experts say tackling the exorbitant cost of health care is as much a top issue for voters as the U.S. economy.
Health care costs in the United States continue to rise — and Americans increasingly say they are unable to afford the care they need.
There is no issue in health care even remotely close to voter frustration over the high prices patients have to pay for medical care, said Drew Altman, president and CEO of KFF, a nonprofit group that researches health policy issues.
“People tend to think about health care as separate from the economy,” he said. “But when you talk to voters, it’s not separate at all in their heads. Health care is a dimension of their pocketbook economic concerns.”
National health care spending is projected to have increased 7.5% in 2023 to almost $4.8 trillion, faster than the projected growth of the overall economy, according to the Centers for Medicare and Medicaid Services.
The estimated health care spending per person — the average amount spent on health care services for each individual — reached $14,423 in 2023, up from $13,493 in 2022 and $13,012 in 2021.
The rising cost is hitting Americans’ wallets. About half of U.S. adults say it is difficult to afford their health care costs, according to a recent poll from KFF. About 1 in 4 say they — or a family member — had problems paying for health care in the past year.
That often means people will have to skip or delay the care that they need, said Dr. Adam Gaffney, a critical care physician at the Cambridge Health Alliance, who was not involved in the polling. A family member may try to provide financial aid, he added, but attempts to help another can sometimes aggravate problems for the entire family — most notably with medical debt.
"For American households, health care costs are one of the most important economic issues," he said. “What we spend on health care is going to be one of the biggest line items for a lot of families, particularly families with children or with elderly people with chronic diseases.”
No sweeping reform
Although Trump has revived threats to dismantle the Affordable Care Act, also known as Obamacare, major health care reform is unlikely to be a central issue during the debate, Altman said.
Biden is likely to tout the Inflation Reduction Act, which he signed into law in 2022.
Among the provisions is allowing Medicare, for the first time, to directly negotiate drug prices with pharmaceutical companies. Earlier this year, the government began negotiating prices on the 10 costliest prescription drugs covered by Medicare, which included heart medications and diabetes drugs. The government is expected to publish the new negotiated prices by Sept. 1.
Aside from Obamacare and abortion, Trump has provided little detail on what health care policy would look like in a potential second term. He made addressing the high cost of prescription drugs a tentpole of his previous term, including a push to allow states to import drugs from Canada and a rule that would tie prices for certain drugs to prices paid by countries overseas.
The greatest challenge for both Biden and Trump will be pitching health care cost policies that both sides of Congress can get behind, said Robin Feldman, a professor of law and director of the Center for Innovation at UC Law San Francisco.
“Notions of unity and compromise seem to be a distant memory in Congress, as they are in the nation,” she said.
”The idea of a big major sweeping reform has felt unlikely in recent years,” Gaffney said.
Breakthrough reforms remain challenging — but important.
“This distinction between health care as an issue and the economy as an issue at this point drives me crazy, because for real people, there is no distinction,” Altman said. “It’s one of their biggest economic concerns.”
Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















